Concise, clinically-relevant information on all U.S. prescription drugs, plus herbal, nutritional and OTC products, and new and investigational drugs. "Clinical Pharmacology is accepted by all 50 state Boards of Pharmacy as a compendium to fulfill the drug reference requirements for licensed pharmacies and is officially recognized by the Centers for Medicare and Medicaid Services (CMS) as a drug compendium for determining the appropriate use of drugs and biologics for cancer patients."
Learn about mobile access | UpToDate® is a physician-authored clinical decision support resource that assists clinicians with point-of-care decisions. Includes easy-to-search graphics and a drug database and drug interactions tool (in partnership with Lexicomp®).
The Medical Letter is a peer-reviewed biweekly publication which provides unbiased critical evaluation of FDA-approved drugs, with a special emphasis on new drugs as well as the appraisal of new drugs for effectiveness, toxicity and cost, and discussion of possible alternatives. A mobile app is available.
To add the Medical Letter on your phone or tablet, first access this publication from the library. Then click on Mobile Apps from the left menu. Sign up for an account. You have access to the app for two years before you are asked to re-register.
Drug reference with brand, generic, and OTC medicines, drug interaction check and pill ID. Available for iOS and Android devices. The full version of the app is available! Call the DMU Helpdesk 271-1522 to learn more. This resource is not managed by the library. Please read the directions provided by the DMU HelpDesk to set up the mobile app.
"The Drug Listing Act of 1972 requires registered drug establishments to provide the Food and Drug Administration (FDA) with a current list of all drugs manufactured, prepared, propagated, compounded, or processed by it for commercial distribution. (See Section 510 of the Federal Food, Drug, and Cosmetic Act (Act) (21 U.S.C. § 360)). Drug products are identified and reported using a unique, three-segment number, called the National Drug Code (NDC), which serves as a universal product identifier for drugs. FDA publishes the listed NDC numbers and the information submitted as part of the listing information in the NDC Directory which is updated daily."